Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Product › Details

Erbitux®

Products Next higher product group cetuximab
Period Status 2004-07-01 sales start
  Annual sales USD 2,016,000,000 (sales (2013) 2013)
Organisations Organisation Merck KGaA
  Group Merck (DE) (Group)
  Organisation 2 ImClone Systems Inc.
  Group Eli Lilly (Group)
  Original research Weizmann Institute of Science
Document Source Merck KGaA. (3/2/20). "Press Release: Erbitux Approved for First-Line Use in China in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) [Not intended for UK-based media]". Darmstadt.
     

   
Record changed: 2024-01-07

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for antibody cancer drug


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner German Biotech Days 2024 in Berlin 650x300px




» top